Pictet Cleaner Planet ETF (PCLN)
Live price chart, market sentiment, and community perspectives for Pictet Cleaner Planet ETF (AMEX: PCLN).
Live price chart, market sentiment, and community perspectives for Pictet Cleaner Planet ETF (AMEX: PCLN).
On our desk, evaluating Pictet's expansion into the U.S. market via NYSE Arca has been an interesting exercise, particularly with the rollout of the Pictet Cleaner Planet ETF (PCLN) alongside their AI and Automation suite. While the firm brings heavy European asset management pedigree, the immediate market reception shows a divergence between strategic novelty and raw performance. We noted that July 2006 (noted as July 2026 in data) brought a sharp -9.2% return, landing the fund a D grade relative to its Global Small/Mid Stock peers. From a market sentiment perspective, investors are balancing the appeal of active thematic management against near-term performance drag and cautious positioning.
Looking at the quantitative profile of PCLN from a risk-management lens, the QuantLogix engine currently pegs the Pictet Cleaner Planet ETF at a Neutral rating with a composite score of -0.05, trading around $31.90. This reflects a period of consolidation or choppy momentum following its recent inclusion in the U.S. active ETF landscape. Risk factors clearly highlight category-relative volatility, as evidenced by the recent dip in performance metrics. Anyone allocating capital here needs to account for the structural behavior of global small-to-mid cap equity strategies operating within specialized environmental sectors, where macro headwinds can disproportionately affect short-term drawdowns.
When analyzing active thematic funds like PCLN for portfolio integration, our core protocol focuses on dissecting the underlying fundamental thesis versus quantitative execution. The SEC filings and summary prospectus updates from late 2025 into January 2026 establish its framework as an actively managed equity vehicle on NYSE Arca. When discussing this fund with institutional clients or preparing research notes, analysts must look past the initial marketing hype of Pictet's U.S. market entry and closely examine how active management navigates sector-specific volatility—especially given recent D-grade category rankings during softer monthly return periods like July.
Explore plasma cleansing, somatic organ swaps, and BCI.